CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at Credit Suisse Healthcare Conference Transcript

Nov 09, 2022 / 04:35PM GMT
Release Date Price: R$51.53 (-1.39%)
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Hello, everyone. I'm A.J. Rice, the health care services analyst at Credit Suisse. We're very pleased to have up next in the room, CVS Health; and Shawn Guertin, the Chief Financial Officer, is with us today.

Questions & Answers

Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Let me just sort of kick it off with an open any question. If you think about this year, Shawn, we're on our 11th month, spent a lot of things that have developed and transpired. But what would you sort of highlight is some of the wins for CVS and maybe some of the challenges?

Shawn Michael Guertin
CVS Health Corporation - Executive VP & CFO

Yes. I think from a big picture perspective, what I'd say really the year has been extremely successful, especially it pertains to '22 and I'll talk a little bit more about it. But if there were a few clouds that popped up, they

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot